BioAffinity Technologies Inc. (BIAF)
NASDAQ · Healthcare
BioAffinity Technologies Inc. Revenue 2022–2025
BioAffinity Technologies Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioAffinity Technologies Inc. revenue for the quarter ending March 31, 2026 was 1.4 M, a 27.09% decrease year-over-year.
- BioAffinity Technologies Inc. revenue for the twelve months ending March 31, 2026 was 5.9 M, a 20.56% decrease year-over-year.
- BioAffinity Technologies Inc. annual revenue for 2025 was 6.2 M, a 34.18% decrease from 2024.
- BioAffinity Technologies Inc. annual revenue for 2024 was 9.4 M, a 269.68% increase from 2023.
- BioAffinity Technologies Inc. annual revenue for 2023 was 2.5 M, a 52627.44% increase from 2022.
- BioAffinity Technologies Inc. annual revenue for 2022 was 4803.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioAffinity Technologies Inc. Market Cap — FAQ
BioAffinity Technologies Inc. (BIAF) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIAF's market cap history?
The chart and table above show BioAffinity Technologies Inc.'s market cap by year and by quarter, including the growth rate.